IoT Medical Devices Market Forecasts to 2030 – Global Analysis By Product ( Vital Signs Monitoring System, Imaging Systems, Implantable Cardiac Devices, Patient Monitors, Respiratory Devices, Infusion Pumps and Other Products), Type ( Wearable, Implantable Device, Stationary Medical Device and Other Types), Connectivity Technology ( Wifi, Bluetooth, Zigbee and Other Connectivity Technology), Application (Telemedicine, Medication Management, Patient Monitoring and Other Applications), End User and By Geography
According to Stratistics MRC, the Global IoT Medical Devices Market is accounted for $50.1 billion in 2023 and is expected to reach $274.1 billion by 2030 growing at a CAGR of 27.5% during the forecast period. The IoT Medical Devices Market in the healthcare industry is focused on the development and utilization of interconnected medical devices that leverage Internet of Things (IoT) technology. These devices, including wearable health trackers, remote monitoring systems, and smart medical equipment, enable the collection, transmission, and analysis of real-time patient data.
According to the Global System for Mobile Communications (GSMA), global smartphone adoption, as a percentage of mobile connections, reached 67% by the end of 2020 and is projected to reach 70% by 2025. By the end of 2022, global mobile service subscriptions surpassed 5.4 billion, with 4.4 billion individuals using mobile internet.
Market DynamicsDriverGovernment initiatives to promote digital health
Many governments worldwide are recognizing the potential of IoT medical devices to improve healthcare accessibility, reduce costs, and enhance patient outcomes. They are implementing policies, regulations, and funding programs to incentivize the adoption of these devices in healthcare systems. This support includes reimbursement schemes, telemedicine regulations, and initiatives for interoperability and data security. As a result, IoT medical device manufacturers and healthcare providers are increasingly encouraged to invest in and adopt these technologies.
RestraintHigh deployment cost of connected medical devices
Integrating IoT technology into healthcare infrastructure requires substantial investment in device procurement, data management, and cybersecurity measures. These costs can be a barrier, especially for smaller healthcare facilities and resource-constrained regions. Additionally, ongoing maintenance and updates further increase the total cost of ownership. While IoT medical devices offer substantial benefits, including improved patient care and reduced healthcare expenses in the long term, the initial financial burden can impede their widespread adoption.
OpportunityEvolution of high-speed networking technologies
Advancements like 5G and low-latency, high-bandwidth networks enable seamless and real-time communication between medical devices and healthcare systems. This opens up new possibilities for remote patient monitoring, telemedicine, and data-intensive applications in healthcare. Healthcare providers can access patient data rapidly and accurately, enhancing diagnostic precision and treatment planning. Moreover, high-speed networking facilitates the secure and efficient transfer of medical data, ensuring patient privacy and regulatory compliance.
ThreatConcerns related to data management and interoperability
Developing user-friendly and ergonomic PCUs that seamlessly integrate with the seat actuation system is a complex task. Ensuring intuitive controls, safety features, and compatibility with the overall cabin design demands significant engineering expertise. Additionally, strict aviation regulations and certification processes further challenge manufacturers. Overcoming these restraints requires investments in research and development to create efficient and reliable PCUs that enhance the overall passenger experience without compromising safety and compliance standards.
Covid-19 ImpactThe healthcare industry is directly impacted by COVID-19 since it is at the forefront of this unprecedented worldwide pandemic issue. The COVID-19 outbreak has caused the demand for IoMT devices to expand rapidly, which has therefore had an effect on the global market. Due to the increase of applications and opportunities, the pandemic is acting as a catalyst for digital transformation. Government agencies, healthcare providers, and people all had to adjust or modify their priorities as a result. Despite the limitations presented by the epidemic, linked gadgets have allowed people to monitor their health, receive virtual diagnoses, and manage it more effectively.
The vital signs monitoring system segment is expected to be the largest during the forecast period
The vital signs monitoring system segment is expected to have lucrative growth, offering real-time tracking and analysis of essential physiological parameters like heart rate, blood pressure, temperature, and oxygen levels. These IoT devices enable continuous remote monitoring of patients, both in clinical settings and at home, providing healthcare professionals with immediate access to crucial data. They play a pivotal role in early disease detection, chronic condition management, and post-operative care, enhancing patient outcomes and reducing hospital readmissions.
The stationary medical device segment is expected to have the highest CAGR during the forecast period
The stationary medical device segment is anticipated to witness the fastest CAGR growth during the forecast period. These devices, integrated with IoT technology, enable real-time monitoring, data collection, and remote management of patient information. Examples include IoT-connected MRI machines, X-ray equipment, and laboratory analyzers. They streamline data transmission, enhance diagnostic accuracy, and enable healthcare professionals to monitor patients more efficiently. Stationary medical devices offer advantages such as improved treatment precision and reduced human error, contributing to better patient outcomes and the overall efficiency of healthcare delivery within institutional settings.
Region with largest shareNorth America holds a significant share in the IoT Medical Devices Market, driven by its advanced healthcare infrastructure, strong research and development capabilities, and supportive regulatory environment. The region boasts a high adoption rate of IoT-enabled medical devices, including wearable health trackers and remote monitoring systems, as healthcare providers seek to improve patient care and outcomes. North America's investment in telemedicine and data-driven healthcare, along with its focus on patient-centric care models, positions it as a frontrunner in leveraging IoT technology to transform and enhance the delivery of healthcare services.
Region with highest CAGRAsia Pacific is projected to have the highest CAGR over the forecast period, fuelled by expanding population, increasing healthcare needs, and growing adoption of digital technologies. With the support of government initiatives and a growing tech-savvy consumer base, IoT medical devices are rapidly gaining acceptance. In addition to improving patient care, they address challenges like remote patient monitoring in rural areas. Asia Pacific's vast market potential, coupled with its commitment to healthcare innovation, positions it as a significant player in the global IoT Medical Devices Market, fostering transformative advancements in healthcare delivery.
Key players in the marketSome of the key players in IoT Medical Devices Market include Honeywell Life Care Solutions, IBM Corporation, iHealth Lab, Cerner Corporation, Cisco Inc, GE Healthcare, Stanley Healthcare, Welch Allyn, Abbott Laboratories, AdhereTech, AgaMatrix, AliveCor, BioTelemetry, Biotronik, Boston Scientific, Capsule Technologies, Inc, Siemens, Medtronic, Meru Health, Omron, Philips, SAP affiliate company, Johnson & Johnson, Koninklijke Philips N.V. and LifeFuels Inc.
Key DevelopmentsIn May 2023, Medtronic (Ireland) acquired EOFlow Co. Ltd. (South Korea) to expand the company’s ability to treat patients with diabetes.
In April 2023, Koninklijke Philips N.V. (Netherlands) and Northwell Health (US) partnered to assist the health system in standardizing patient monitoring, improving patient care, and improving patient outcomes while promoting interoperability and data innovation.
In March 2023, Abbott (US) acquired Cardiovascular Systems, Inc. (CSI) (US) to gains a complementary treatment option for vascular illness. The most advanced atherectomy technology from CSI prepares vessels for angioplasty or stenting to restore blood flow.
Products Covered
• Vital Signs Monitoring System
• Imaging Systems
• Implantable Cardiac Devices
• Patient Monitors
• Respiratory Devices
• Infusion Pumps
• Fetal Monitoring Devices
• Neurological Devices
• Ventilators
• Anesthesia Machines
• Hearing Devices
• Other Products
Types Covered
• Wearable
• Implantable Device
• Stationary Medical Device
• Other Types
Connectivity Technologies Covered
• Wifi
• Bluetooth
• Zigbee
• Other Connectivity Technologies
Applications Covered
• Telemedicine
• Medication Management
• Patient Monitoring
• Other Applications
End Users Covered
• Healthcare Providers
• Government Authorities
• Other End Users
Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements